Systematic review and meta-analysis of studies comparing baseline D-dimer level in stroke patients with or without cancer: Strength of current evidence.
Rakesh Kumar MishraVishal K ChavdaLuis Rafael Moscote-SalazarOday AtallahSaikat DasTariq JanjuaVed Prakash MauryaAmit AgrawalPublished in: Journal of neurosciences in rural practice (2024)
D-dimer is a simple and relatively non-expensive biomarker that is increased to significant levels in stroke patients, who have cancer and therefore may be a tool to predict through screening for active or occult cancer in stroke patients.